Shanghai Fosun Pharmaceutical (Group) Co Ltd (SFOSF)
1.695
0.00 (0.00%)
USD |
OTCM |
May 20, 16:00
Shanghai Fosun Pharmaceutical Shareholders Equity (Quarterly): 6.513B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.513B |
December 31, 2023 | 6.445B |
September 30, 2023 | 6.294B |
June 30, 2023 | 6.267B |
June 30, 2023 | 6.267B |
March 31, 2023 | 6.596B |
December 31, 2022 | 6.462B |
September 30, 2022 | 6.108B |
June 30, 2022 | 5.700B |
June 30, 2022 | 5.700B |
March 31, 2022 | 6.029B |
December 31, 2021 | 6.149B |
September 30, 2021 | 6.017B |
June 30, 2021 | 5.856B |
June 30, 2021 | 5.856B |
March 31, 2021 | 5.727B |
December 31, 2020 | 5.663B |
September 30, 2020 | 4.846B |
June 30, 2020 | 4.659B |
June 30, 2020 | 4.659B |
March 31, 2020 | 4.603B |
December 31, 2019 | 4.558B |
September 30, 2019 | 4.300B |
June 30, 2019 | 4.171B |
June 30, 2019 | 4.171B |
Date | Value |
---|---|
March 31, 2019 | 4.278B |
December 31, 2018 | 4.067B |
September 30, 2018 | 4.149B |
June 30, 2018 | 3.857B |
June 30, 2018 | 3.857B |
March 31, 2018 | 4.122B |
December 31, 2017 | 3.879B |
September 30, 2017 | 3.831B |
June 30, 2017 | 3.633B |
June 30, 2017 | 3.633B |
March 31, 2017 | 3.310B |
December 31, 2016 | 3.195B |
September 30, 2016 | 2.941B |
June 30, 2016 | 2.861B |
June 30, 2016 | 2.861B |
March 31, 2016 | 2.893B |
December 31, 2015 | 2.801B |
September 30, 2015 | 2.759B |
June 30, 2015 | 2.816B |
June 30, 2015 | 2.816B |
March 31, 2015 | 2.819B |
December 31, 2014 | 2.688B |
September 30, 2014 | 2.728B |
June 30, 2014 | 2.480B |
June 30, 2014 | 2.480B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.171B
Minimum
Jun 2019
6.596B
Maximum
Mar 2023
5.585B
Average
5.856B
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
Sinovac Biotech Ltd | 8.709B |
CASI Pharmaceuticals Inc | 15.47M |
Zai Lab Ltd | 762.17M |
Gracell Biotechnologies Inc (DELISTED) | 222.18M |
Adagene Inc | 70.56M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 15.98B |
Total Liabilities (Quarterly) | 7.899B |
Debt to Equity Ratio | 0.7098 |
Current Ratio | 1.007 |
Net Debt Paydown Yield | -1.55% |